Spatiotemporal changes in effector immunity in response to checkpoint blockade immune therapy in acute myeloid leukemia

被引：0
|
作者：
David, Harris [1 ]
Usher, Lindsay [1 ]
Thi Bui [1 ]
Belle, Ian [1 ]
Rainbolt, Elizabeth [1 ]
Kidder, Shasta [1 ]
Meshaw, Kay [1 ]
Hall, Chassidy [1 ]
Mahajan, Vivek [1 ]
机构：
[1] Charles River Discovery Serv, Morrisville, NC USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-LB-191
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-191
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The role of IFN-γ-signalling in response to immune checkpoint blockade therapy
    Wong, Chun Wai
    Huang, Yang Yu
    Hurlstone, Adam
    ESSAYS IN BIOCHEMISTRY, 2023, 67 (06) : 991 - 1002
  • [42] Pharmacodynamics of immune checkpoint blockade therapy indicate drivers of response.
    Grasso, Catherine S.
    Tsoi, Jennifer
    Abril-Rodriguez, Gabriel
    Quist, Michael J.
    Ross-MacDonald, Petra
    Wind-Rotolo, Megan
    Ribas, Antoni
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (04) : 40 - 41
  • [43] Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
    Noam Auslander
    Gao Zhang
    Joo Sang Lee
    Dennie T. Frederick
    Benchun Miao
    Tabea Moll
    Tian Tian
    Zhi Wei
    Sanna Madan
    Ryan J. Sullivan
    Genevieve Boland
    Keith Flaherty
    Meenhard Herlyn
    Eytan Ruppin
    Nature Medicine, 2018, 24 : 1545 - 1549
  • [44] VHLloss enables immune checkpoint blockade therapy by boosting interferon response
    Jiao, Meng
    Bao, Xuhui
    Hu, Mengjie
    Pan, Dong
    Kim, Jonathan
    Liu, Xinjian
    Li, Fang
    Li, Chuan-Yuan
    CANCER RESEARCH, 2023, 83 (07)
  • [45] Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
    Auslander, Noam
    Zhang, Gao
    Lee, Joo Sang
    Frederick, Dennie T.
    Miao, Benchun
    Moll, Tabea
    Tian, Tian
    Wei, Zhi
    Madan, Sanna
    Sullivan, Ryan J.
    Boland, Genevieve
    Flaherty, Keith
    Herlyn, Meenhard
    Ruppin, Eytan
    NATURE MEDICINE, 2018, 24 (10) : 1545 - +
  • [46] Transcriptomic Features of Immune Exhaustion and Senescence Predict Outcomes and Define Checkpoint Blockade-Unresponsive Microenvironments in Acute Myeloid Leukemia
    Rutella, Sergio
    Vadakekolathu, Jayakumar
    Mazziotta, Francesco
    Reeder, Stephen
    Yau, Tung On
    Mukhopadhyay, Rupkatha
    Altmann, Heidi
    Kramer, Michael
    Knaus, Hanna A.
    Zeidner, Joshua F.
    Radojcic, Vedran
    Arruda, Andrea
    Minden, Mark D.
    Tasian, Sarah K.
    Bornhaeuser, Martin
    Gojo, Ivana
    Luznik, Leo
    BLOOD, 2021, 138
  • [47] Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade
    Peranzoni, Elisa
    Ingangi, Vincenzo
    Masetto, Elena
    Pinton, Laura
    Marigo, Ilaria
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [48] Defining the Immune Checkpoint Landscape in Patients (pts) with Acute Myeloid Leukemia (AML)
    Daver, Naval
    Basu, Sreyashi
    Garcia-Manero, Guillermo
    Cortes, Jorge E.
    Ravandi, Farhad
    Ning, Jing
    Xiao, Lianchun
    Juliana, Lopez
    Kornblau, Steven M.
    Konopleva, Marina
    Andreeff, Michael
    Flores, Wilmer
    Bueso-Ramos, Carlos E.
    Somani, Narmeen
    Blando, Jorge
    Allison, James
    Kantarjian, Hagop M.
    Sharma, Padmanee
    BLOOD, 2016, 128 (22)
  • [49] Checkpoint Inhibitors and Other Immune-Based Therapies in Acute Myeloid Leukemia
    Haddad, Fadi
    Zeidan, Amer M.
    Daver, Naval
    CANCER JOURNAL, 2022, 28 (01): : 43 - 50
  • [50] Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: Novel Combinations and Therapeutic Targets
    Maximilian Stahl
    Aaron D. Goldberg
    Current Oncology Reports, 2019, 21
12345